QuidelOrtho (QDEL)
(Real Time Quote from BATS)
$48.67 USD
+0.41 (0.85%)
Updated Mar 28, 2024 10:54 AM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum D VGM
Income Statements
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,998 | 3,266 | 1,699 | 1,662 | 535 |
Cost Of Goods | 1,503 | 1,330 | 428 | 313 | 214 |
Gross Profit | 1,494 | 1,936 | 1,271 | 1,349 | 321 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,355 | 1,092 | 365 | 289 | 228 |
Income After Depreciation & Amortization | 139 | 844 | 906 | 1,060 | 93 |
Non-Operating Income | -21 | -32 | 0 | -10 | -1 |
Interest Expense | 148 | 76 | 6 | 10 | 15 |
Pretax Income | -29 | 736 | 900 | 1,040 | 77 |
Income Taxes | -19 | 187 | 196 | 230 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -10 | 549 | 704 | 810 | 73 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -10 | 549 | 704 | 810 | 73 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 596 | 1,117 | 965 | 1,117 | 154 |
Depreciation & Amortization (Cash Flow) | 457 | 273 | 59 | 56 | 62 |
Income After Depreciation & Amortization | 139 | 844 | 906 | 1,060 | 93 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 66.80 | 57.40 | 42.87 | 43.59 | 43.11 |
Diluted EPS Before Non-Recurring Items | 4.13 | 13.76 | 17.27 | 19.55 | 2.73 |
Diluted Net EPS (GAAP) | -0.15 | 9.56 | 16.43 | 18.60 | 1.73 |
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 742.60 | 744.00 | 665.10 | 846.10 | 866.54 |
Cost Of Goods | 361.30 | 375.90 | 368.70 | 397.50 | 415.50 |
Gross Profit | 381.30 | 368.10 | 296.40 | 448.60 | 451.04 |
SG&A, R&D, and Dept/Amort Expenses | 341.20 | 341.80 | 323.30 | 349.00 | 364.50 |
Income After SG&A, R&D, and Dept/Amort Expenses | 40.10 | 26.30 | -26.90 | 99.60 | 86.54 |
Non-Operating Income | -12.60 | -4.10 | -1.00 | -2.90 | -9.80 |
Interest Expense | 36.70 | 37.70 | 36.50 | 36.70 | 35.67 |
Pretax Income | -9.20 | -15.50 | -64.40 | 60.00 | 41.07 |
Income Taxes | -16.20 | -2.80 | -11.20 | 11.20 | 10.81 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 7.00 | -12.70 | -53.20 | 48.80 | 30.26 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 7.00 | -12.70 | -53.20 | 48.80 | 30.26 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 67.30 | 66.90 | 66.80 | 67.10 | 66.90 |
Diluted EPS Before Non-Recurring Items | 1.17 | 0.90 | 0.26 | 1.79 | 1.74 |
Diluted Net EPS (GAAP) | 0.11 | -0.19 | -0.80 | 0.73 | -2.39 |